Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 15/20 | 0.64 |
| ▸ | LPAR2 | Q9HBW0 | 13/20 | 0.64 |
| ▸ | LPAR1 | Q92633 | 10/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.43 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26234272 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL9676047 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL6701668 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL5453677 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL649061 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL7948187 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL1262956 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL4436297 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL11025774 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL2716235 | 1.00 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR6LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115652313-A | Long-chain efficient metal pickling corrosion inhibitor and application thereof | 四川文理学院 | 2023-01-31 | — | — | CN | claimed |
| US-4148981-A | Dithiophosphorylated copolymers of aziridineethyl acrylates or methacrylates and alkyl acrylates or methacrylates | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| CN-115652313-A | Long-chain efficient metal pickling corrosion inhibitor and application thereof | 四川文理学院 | 2023-01-31 | — | — | CN | disclosed |
| US-7422620-B2 | Process for producing copper nanoparticles | LANZHOU INSTITUTE OF OF CHEMICAL PHYSICS (CN) | 2008-09-09 | — | — | US | disclosed |
| US-20070117847-A1 | N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | CHAMBERS MARK S | 2007-05-24 | — | — | US | disclosed |
| US-7153868-B2 | N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | MERCK SHARP & DOHME LTD. | 2006-12-26 | — | — | US | disclosed |
| US-20060053972-A1 | Process for producing copper nanoparticles | LANZHOU INSTITUTE OF CHEMICAL PHYSICS (CN) | 2006-03-16 | — | — | US | disclosed |
| US-20040002504-A1 | N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | MERCK SHARP & DOHME LTD. (GB) | 2004-01-01 | — | — | US | disclosed |
| WO-2003030898-A1 | MODULATORS OF CCR5 CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-6511994-B2 | For prophylaxis and therapy of infection by HIV and the treatment of AIDS | MERCK & CO., INC. | 2003-01-28 | — | — | US | disclosed |
| US-20020193407-A1 | Modulators of CCR5 chemokine receptor activity | MERCK SHARP & DOHME CORP. | 2002-12-19 | — | — | US | disclosed |
| US-5942470-A | OIL SOLUBLE SULFUR CONTAINING PRESSURE AND ANTI-WEAR AGENT, AMINE SALT OF PHOSPHORUS ESTER, SUCCINIMIDE, AND ASHLESS DISPERSANTS | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0459656-B1 | Lubricant compositions | ETHYL PETROLEUM ADDITIVES INC (US) | 1995-09-20 | — | — | EP | disclosed |
| EP-0459656-A1 | Lubricant compositions | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1991-12-04 | — | — | EP | disclosed |
| US-4148981-A | Dithiophosphorylated copolymers of aziridineethyl acrylates or methacrylates and alkyl acrylates or methacrylates | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193407-A1 | Modulators of CCR5 chemokine receptor activity | CCR5, CXCR3, CXCR1 | LPAR3 285/4885LPAR2 500/4885LPAR1 201/4885 |
| US-20040002504-A1 | N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | KCNH3, KCNH2, KCNK3 | LPAR3 205/4885LPAR2 660/4885LPAR1 397/4885 |
| US-20070117847-A1 | N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists | TACR2, KCNK3, KCNH3 | LPAR3 315/4885LPAR2 1414/4885LPAR1 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.